Sanjay Mookim, Head of India Equity Research at JPMorgan, says long-only investors are showing renewed interest in Indian equities, although high US bond yields could limit emerging-market flows. Mookim remains positive on financials, pharma, healthcare, defence and select power stocks, while preferring consumer discretionary over expensive staples.
